ERBB2 and metastatic malignant neoplasm in the lymph nodes: There were no significant differences in the positive rates of HER-2, ER, PR, Ki-67, pathological types, clavicular lymph node metastasis, and skin chest wall invasion between the two groups (P > 0.05) (Table 4).